LODOSYN Drug Patent Profile
✉ Email this page to a colleague
When do Lodosyn patents expire, and what generic alternatives are available?
Lodosyn is a drug marketed by Aton and is included in one NDA.
The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carbidopa profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lodosyn
A generic version of LODOSYN was approved as carbidopa by ALVOGEN on January 8th, 2016.
Summary for LODOSYN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 10 |
Patent Applications: | 4,806 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LODOSYN |
What excipients (inactive ingredients) are in LODOSYN? | LODOSYN excipients list |
DailyMed Link: | LODOSYN at DailyMed |
Recent Clinical Trials for LODOSYN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Miami | Phase 2 |
Daniel Claassen | Phase 1 |
University of Miami | Phase 1 |
US Patents and Regulatory Information for LODOSYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aton | LODOSYN | carbidopa | TABLET;ORAL | 017830-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LODOSYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aton | LODOSYN | carbidopa | TABLET;ORAL | 017830-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Aton | LODOSYN | carbidopa | TABLET;ORAL | 017830-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Aton | LODOSYN | carbidopa | TABLET;ORAL | 017830-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LODOSYN
See the table below for patents covering LODOSYN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1343407 | ⤷ Try a Trial | |
Yugoslavia | 185778 | ⤷ Try a Trial | |
Yugoslavia | 35107 | ⤷ Try a Trial | |
Germany | 2029823 | ⤷ Try a Trial | |
Romania | 62503 | ⤷ Try a Trial | |
Switzerland | 566298 | L-alpha-hydrazino-beta-phenylpropionic acid compounds - decarboxylase inhibitors | ⤷ Try a Trial |
Yugoslavia | 307970 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |